| Study | Number of participants | Finished number | Age y | Mean age y | Course of disease Y(m) | experiment | control | Duration | Outcomes (primary/secondary outcome) | BMI | Operation | Starting time |
| Weimin Yi2011 | E:40 C:40 | E:40 C:40 | 20-70 | E:46.2±8.6 C:46.9±8.9
| | EA | VitaminB12 | 2w, 5 days a week | Therapeutic effect, residual urine volume | E:23.6±5.6 C: 24.2±6.1 | Radical Hysterectomy | 15 day |
| Changhai He 2010 | E:32 C:15 | E:32 C:15 | | E:73.9 C:73.5 | | EA | Basic nursingr+Adrenergic α1 receptor blockade | 4W, | Therapectic effect | | Prostatectomy | 6-8 day |
| Jie Zhu 2005 | E:53(m30,f23) C:57(m35,f22) | E:53 C:57 | E:19-71 C:22-75 | E:46 C:43 | | EA+moxibustion | neostigmine | | Therapeutic effect | | anal fistula operation, mixed hemorrhoid operation,anal fissure operation | |
| Weimin Yi2014 | E:60 C:60 | E:58 C:57 | 20-65 | E:46.5±7.7 C:45.9±8.2 | | EA | SA | 3W | Therapeutic effect, residual urine volume, bladder capacity, maximum urinary flow rate, urine output | E:24.3 ±3.4 C:25.1 ±3.3 | radical hysterectomy | 6 day |
| Huawe Xiao 2015 | E:50(m28,f22) C:50(m23,f27) | E:50 C:50 | E:19-65 C:20-66 | E: 42. 56± 11. 68 C:41.09± 12. 87 | E: 8. 78±4. 56 C:9. 04±5. 37 | EA | Tylox | 3 days | Therapeutic effect | | Anorectal surgery | |
| Liang Chen 2007 | E:35 C:36 | E:35 C:36 | | | | EA | No treatment | | Therapeutic effect | | anus operation | |
| Chenyang Zhi 2011 | E:32(m17,f15) C:30(m11,f19) | E:32 C:30 | 24-65 | E:47.5±17.5 C:43.5±19.5 | | EA | No treatment | 30min | Therapeutic effect | | anus operation | |
| Liang Chen 2010 | E:30(m14,f16) C:30(m17,f13) | E:30 C:30 | | | | EA | No treatment | | Therapeutic effect, first urination time | | | |
| Hengjun Ma 2010 | E:60(m33,f27) C:60(m31,f29) | E:60 C:60 | E:16-65 C:20-64
| E:45.5 C:44.6 | | EA+Chinese medicine liquid | No treatment | 3 days | Therapeutic effect | | Mixed hemorrhoid surgery | |
| Weimin Yi2008 | E:55 C:55 | E:55 C:55 | 20-70 | E:47.5±7.8 C:46.3±8.2 | | EA+basic nursing+TDP | Basic nursing+TDP | 5 days, once a day | Therapeutic effect, residual urine volume, bladder capacity, maximum urinary flow rate | E:22.3 ±2.3 C:22.6 ±2.5 | Extensive hysterectomy | 8 day |
| Xiaoling Xi 2010 | E:31 C:31 | E:31 C:31 | 26-65 | 44.4 | | EA+PFMT+basic nursing | PFMT+basic nursing | 5 days, once a day | Therapeutic effect, residual urine volume | | Extensive hysterectomy, pelvic lymph node dissection | 6 day |
| Chengxin Li 2015 | E:33(m19,f14) C:34(m20,f15) | E:33 C:34 | E:21-61 C:19-62 | E:43±12 C:44±11 | | EA+PFMT+basic nursing | Basic nursing | 2w, once a day | Therapeutic effect, residual urine volume, first urination time | | | |
| Xianfeng Hu 2015 | E:42 C:42 | E:42 C:42 | | E:48.5±10.4 C:47.9±12.4 | | EA+TCM nursing | Basic nursing | 2w, once a day | Therapeutic effect, residual urine volume | | Radical Hysterectomy | 16 day |
| Haidong Peng 2009 | E:23 C:23 | E:23 C:23 | E:26-69 C:24-66 | E:34 C:35 | 7-14d | EA+gingeer moxibustion | neostigmine | 5 days, once a day | Therapeutic effect | | Radical Hysterectomy | 8-15 day |
| Dongbin Xia 2007 | E:40(m23,f17) C:40(m25,f15) | E:40 C:40 | E:23-68 C:25-70 | E:43.65 C:45.45 | | EA | neostigmine | 20min | Therapeutic effect | | anal fistula operation, mixed hemorrhoid operation, anal fissure operation | |
| Xuenong Chen 2006 | E:30 C:30 | E:30 C:30 | E:35-69 C:33-68 | E:39.51 C:39.5 | 2-5d | EA | neostigmine | 5 days, twice a day | Therapeutic effect | | Cervical cancer surgery | 3-6 day |
| Yan Li 2004 | E:52 C:52 | E:52 C:52 | E:24-69 C:25-66 | E:32.5 C:34.46 | 7-14d | EA | neostigmine | 1w, once a day | Therapeutic effect | | Extensive hysterectomy | 8-15 day |
| Shengjia Zhao 2015 | E:30 C:30 | E:30 C:30 | E:60-74 C:60-75 | E:63.7±3.2 C:64.2±2.7 | 7-14d | EA+PFMT+Bromides | PFMT+Bromides | 20 days | Therapeutic effect, residual urine volume, bladder capacity, maximum urinary flow rate, urine output | | Cervical cancer surgery | 8-15 day |
| Peizhi Ye 2014 | E:74 C:33 | E:74 C:33 | | E:46.92±13.69 C:46.26±12.89 | E:94.12±65.36 C:85.34±73.67 d | EA+basic nursing | Basic nursing | 10 days, once a day | Therapeutic effect, residual urine volume | | Cervical cancer surgery | 5 day |
| Bimei He 2015 | E:80(m45,f35) C:74(m39,f35) | E:80 C:74 | E:20-76 C:19-76 | E:45±16 C:48±16 | | EA | No treatment | 30min | Therapeutic effect, first urination time, urine output | | Spinal anesthesia | |
| Xu Han 2017 | E:38(m28,f10) C:38(m26,f22) | E:38 C:38 | E:46-78 C:44-78 | E:59.8±9.14 C: 58.2±8.33 | | EA | Tamsulosin hydrochloride | 3 day, once a day | Therapeutic effect, residual urine volume, first urination time, urine output | | Hartmann, Dixon, Miles surgery | |
| Liubo Fan 2010 | E:10(m6,f4) C:10(m5,f5) | E:10 C:10 | | E:57±14 C:55±11 | E:9.3±1.5 C:9.1±3.7m | EA | Basic nursing | 20 days, 5 times a week | Residual urine volume, maximum urinary flow rate | | Pelvic fracture surgery | Half a year |
| Yinqiu Gao 2014 | E:31(m10,f21) C:30(m9,f21) | E:31 C:28 | 18-65 | E:55 ± 6 C:53 ± 11 | | EA | No treatment | 30min | First urination time, urine output | | Arthroscopic knee surgery | |
|
|